Biotech

All Articles

Turnstone gives up 60%, agitates C-suite to stretch out money

.Turnstone Biologics is actually decreasing its own head count through 60% as well as shocking its o...

Gilead quits on $15M MASH bet after mulling preclinical records

.In a year that has actually seen a permission and also a boating of readouts for metabolic dysfunct...

Texas biotech axes cancer cells treaty, pins wishes on weight problems

.Alaunos Therapeutics is axing a deal along with Precigen, quiting licensing liberties to a customiz...

Capricor reveals extra records for DMD treatment after starting BLA

.Capricor Rehabs is taking a triumph tour for their phase 2 Duchenne muscular dystrophy (DMD) test. ...

FDA locations Kezar lupus trial in hold observing 4 client fatalities

.The FDA has actually placed Kezar Life Sciences' lupus test on hold after the biotech hailed 4 deat...

Phase 3 Scholar Stone trial reaches SMA goal, delivering stock up 200%

.A period 3 trial of Scholar Rock's vertebral muscular degeneration (SMA) prospect has hit its own m...

CAMP 4 is most recent to eye IPO, while Upstream define $182M program

.RNA biotech CAMP4 Rehabs has marked out think about a $67 million IPO, along with inflammation-focu...

Galecto buys leukemia medication, falls bone tissue cancer resource in pivot

.A year after the breakdown of an idiopathic lung fibrosis applicant sent out Galecto on a search fo...

Judo tosses down $100M to knock senseless kidney illness

.Taking the mat is actually Judo Bio, a promising biotech armed with $one hundred million to cultiva...

AstraZeneca pays out CSPC $100M for preclinical heart problem drug

.AstraZeneca has paid off CSPC Drug Team $one hundred million for a preclinical heart attack medicin...